Jul 3, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
The Uptake Of Key Agents Such As Januvia, Bydureon And Byetta Will Drive The Type 2 D
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2314884" data-attributes="member: 124445"><p>Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of key agents such as Merck's Januvia, Eli Lilly/Amylin/Alkermes' Bydureon and Amylin/Eli Lilly's Byetta will drive the type 2 diabetes drug market to nearly double from $19 billion in 2009 to $36 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan...<a href="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/WKR3E2QCyyo" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/WKR3E2QCyyo/3K9q" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2314884, member: 124445"] Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of key agents such as Merck's Januvia, Eli Lilly/Amylin/Alkermes' Bydureon and Amylin/Eli Lilly's Byetta will drive the type 2 diabetes drug market to nearly double from $19 billion in 2009 to $36 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan...[URL="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/0/da"][IMG]http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/1/da"][IMG]http://feedads.g.doubleclick.net/~a/ms7M92br7bn2n01Df7H7QnsMYH8/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/WKR3E2QCyyo[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/WKR3E2QCyyo/3K9q]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top